Example: bachelor of science
NEW ZEALAND DATA SHEET - Medsafe
Page 1 of 4 NEW ZEALAND DATA SHEET 1. PRODUCT NAME GLYCOPHOS 306.1 mg/mL Infusion, concentrate 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
VINORELBINE 10MG/ML CONCENTRATE FOR …
www.mhra.gov.ukMHRA-UKPAR – Vinorelbine 10mg/ml concentrate for solution for infusion PL 33410/0041 -2 - VINORELBINE 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
Zometa data sheet - Medsafe Home Page
www.medsafe.govt.nz1 . NEW ZEALAND DATA SHEET . 1 PRODUCT NAME ZOMETA® 4 mg/5 mL Liquid Concentrate for Solution for Infusion and 4 mg powder and solvent for solution for infusion.* 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
MATERIAL SAFETY DATA SHEET - pfizer.com
www.pfizer.com1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Material Name: Alprostadil Concentrate for Solution for Infusion Trade Name: Prostin VR Pediatric Sterile Solution; Prostivas
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euFasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion.
NORADRENALINE NOREPINEPHRINE 1 MG ML …
www.mhra.gov.ukMHRA PAR; NORADRENALINE (NOREPINEPHRINE) 1 MG / ML CONCENTRATE FOR SOLUTION FOR INFUSION, PL 31980/0001 2 Lay summary The Medicines and Healthcare products Regulatory Agency (MHRA) granted
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.ukPage 1 of 6 Package leaflet: Information for the user Zinforo ® 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil
Defined Daily Doses Pharmacological Dispensing …
www.who.intAminophylline Aminophylline 23.973mg/ml Solution for injection 600mg Xanthine - Bronchodilator R03DA05 PoM Cordarone® Scored tablet Amiodarone® Cardilor 200 Cordarone® 150mg Solution for injection
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu4 The recommended dose of Avastin when used in addition to erlotinib is 15 mg/kg of body weight given once every 3 weeks as an intravenous infusion.
Related search queries
VINORELBINE, CONCENTRATE FOR, Concentrate for solution for infusion, NEW ZEALAND DATA SHEET, For solution for infusion, Solution, PRODUCT, NORADRENALINE NOREPINEPHRINE 1 MG ML, NORADRENALINE (NOREPINEPHRINE) 1 MG / ML CONCENTRATE FOR SOLUTION FOR INFUSION, Package leaflet: Information for the user, Defined Daily, Infusion